Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. Planchard D, Janne PA, Cheng Y, Yang JC, et al. N Engl J Med 2023;389:1935-1948.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Planchard D, Janne PA, Cheng Y, Yang JC, et al. Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. N Engl J Med 2023;389:1935-1948.
PMID: 37937763